Non-lipidated variants of Neisseria meningitidis ORF2086 antigens
US9757443B2 · kind B2 · utility
16Cited by
64References
11Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 11, 2011 |
| Grant date | Sep 12, 2017 |
| Priority date | — |
| Expiry date | Nov 11, 2031 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to compositions including an isolated non-pyruvylated non-lipidated ORF2086 polypeptide, and methods thereof. In an exemplary embodiment, the compositions described herein are immunogenic. The present invention further relates to compositions that elicit a bactericidal immune response in a mammal against an ORF2086 subfamily B polypeptide from serogroup B Neisseria meningitidis, and methods related thereto.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.